---
layout: archive
title: "emsfc"
permalink: /emsfc/
author_profile: true
---

# Veille bibliographique sur l'EM/SFC

<hr class="hr_gradient" />

## Travaux à feuilleter (résumé à venir) :

**Immuno / endocrino :**
   - [Autoantibodies to selenoprotein P in chronic fatigue syndrome suggest selenium transport impairment and acquired resistance to thyroid hormone](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338150/), Sun et al., Redox Biology, 2023/07

**Neuro, travaux de Angus Mackay :**
   - [A neuroinflammatory paradigm can explain Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post-COVID-19 Fatigue Syndrome](https://ourarchive.otago.ac.nz/handle/10523/15089), manuscrit de thèse, 03/2023
   - [A Paradigm for Post-Covid-19 Fatigue Syndrome Analogous to ME/CFS](https://www.frontiersin.org/articles/10.3389/fneur.2021.701419/full), Frontiers in Neurology, 2021/08
   - [A neuro-inflammatory model can explain the onset, symptoms and flare-ups of myalgic encephalomyelitis/chronic fatigue syndrome](https://www.publish.csiro.au/hc/HC19041), J. of Primary Health Care, 2019/11
   - [Current Research Provides Insight into the Biological Basis and Diagnostic Potential for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)](https://www.mdpi.com/2075-4418/9/3/73), Diagnostics, 2019/07

<hr class="hr_gradient" />



## Résumés de publications :
<small_emphasis>(pour journal club en français)</small_emphasis>

----

### Résultats positifs *(i.e. résultat statistiquement significatif qui appuie une hypothèse)*

#### --- 2023 ---
  + [![acylcarnitine](../files/EMSFC/2023-06_acylcarnitine_vignette.png){:class="img-vignette"}](../files/EMSFC/2023-06_acylcarnitine.html)  
  <hr/>
  + [![butyrate_dysbiosis](../files/EMSFC/2023-02_Gut-microbiome-butyrate_vignette.png){:class="img-vignette"}](../files/EMSFC/2023-02_Gut-microbiome-butyrate.html)  
  <hr/>
  + [![gdf15](../files/EMSFC/2023-03_GDF15-differentiate-patients_vignette.png){:class="img-vignette"}](../files/EMSFC/2023-03_GDF15-differentiate-patients.html)  
  <hr/>
  + [![circulating_miRNA](../files/EMSFC/2023-02_Circulating-miRNA_vignette.png){:class="img-vignette"}](../files/EMSFC/2023-02_Circulating-miRNA.pdf)  
  <hr/>
  + [![transcriptomic-changes](../files/EMSFC/2023-01_Exercice-transcriptomic-changes_vignette.png){:class="img-vignette"}](../files/EMSFC/2023-01_Exercice-transcriptomic-changes.pdf)
  + [![endothelial_dysfonction](../files/EMSFC/2023-02_Endothelial-dysfonction_vignette.png){:class="img-vignette"}](../files/EMSFC/2023-02_Endothelial-dysfonction.pdf)  

#### --- 2022 ---
  +  [![transcriptomic-changes](../files/EMSFC/2022-12_Muscle-sodium-content_vignette.png){:class="img-vignette"}](../files/EMSFC/2022-12_Muscle-sodium-content.pdf)  
  <hr/>
  + [![oxygen_biomarker](../files/EMSFC/2022-03_Oxygen-biomarker_vignette.png){:class="img-vignette"}](../files/EMSFC/2022-03_Oxygen-biomarker.pdf)

<!--### --- 2016 ---
+  [![MM-vs-SFC](../files/EMSFC/2016-06_MM-vs-SFC_vignette.png){:class="img-vignette"}](../files/EMSFC/2016-06_MM-vs-SFC.html)-->

----

### Résultats négatifs *(i.e. résultat n'ayant pas permis de confirmer une hypothèse)*
  + [![tcell](../files/EMSFC/2023-07_Tcell_vignette.png){:class="img-vignette"}](../files/EMSFC/2023-07_Tcell.html)  

<!-- + [![circRNA](../files/EMSFC/2023-06_circRNA_vignette.png){:class="img-vignette"}](../files/EMSFC/2023-06_circRNA.html)  
<hr/>-->
